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Persistence within dendritic cells 
marks an antifungal evasion 
and dissemination strategy of 
Aspergillus terreus
Shih-Hung Hsieh1,2, Oliver Kurzai3,4 & Matthias Brock1
Aspergillus terreus is an airborne human fungal pathogen causing life-threatening invasive aspergillosis 
in immunocompromised patients. In contrast to Aspergillus fumigatus, A. terreus infections are 
associated with high dissemination rates and poor response to antifungal treatment. Here, we 
compared the interaction of conidia from both fungal species with MUTZ-3-derived dendritic cells 
(DCs). After phagocytosis, A. fumigatus conidia rapidly escaped from DCs, whereas A. terreus conidia 
remained persisting with long-term survival. Escape from DCs was independent from DHN-melanin, 
as A. terreus conidia expressing wA showed no increased intracellular germination. Within DCs A. 
terreus conidia were protected from antifungals, whereas A. fumigatus conidia were efficiently 
cleared. Furthermore, while A. fumigatus conidia triggered expression of DC activation markers 
such as CD80, CD83, CD54, MHCII and CCR7, persistent A. terreus conidia were significantly less 
immunogenic. Moreover, DCs confronted with A. terreus conidia neither produced pro-inflammatory 
nor T-cell stimulating cytokines. However, TNF-α addition resulted in activation of DCs and provoked 
the expression of migration markers without inactivating intracellular A. terreus conidia. Therefore, 
persistence within DCs and possibly within other immune cells might contribute to the low response of 
A. terreus infections to antifungal treatment and could be responsible for its high dissemination rates.
Invasive fungal infections cause major health problems especially in critically ill and immunocompromised 
patients. It has been estimated that Candida, Aspergillus, Cryptococcus and Pneumocystis species cause about 
two million infections each year1. Patients at risk for invasive aspergillosis frequently suffer from haemato-
logical malignancies, chronic lymphoproliferative disorders or underwent allogeneic stem cell or solid organ 
transplantation2. As Aspergillus species are ubiquitous in the environment and produce airborne conidia, the 
lung is the primary target organ through inhalation of conidia. Although Aspergillus fumigatus contributes to 
68–72% of cases of invasive aspergillosis and is therefore the major pathogenic species2, 3, Aspergillus terreus is 
responsible for 3–12% of all cases and numbers have been increasing in recent years4, 5. In contrast to A. fumig-
atus, invasive infections by A. terreus show high rates of dissemination to secondary organs6 and, despite the 
use of recommended therapeutic approaches, invasive aspergillosis by A. terreus only shows poor response to 
antifungal treatment4. Therefore, mortality rates from A. terreus infections are even higher than those caused by 
other Aspergillus species4.
The innate immune system plays an important role in clearing Aspergillus infections7. After entering the 
respiratory tract, Aspergillus conidia are recognized by various pattern recognition receptors, such as C-type 
lectin receptors, or toll-like receptors7, 8, which are widely expressed on the surface of immune cells8, 9. Several 
studies have shown that alveolar macrophages and neutrophils are essential immune cells in orchestrating 
the immune response, controlling and eliminating Aspergillus conidia7–9. However, some striking differences 
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in conidia interactions of A. fumigatus and A. terreus with immune cells have been observed10. Once phago-
cytosed by macrophages, the dihydroxynapthalene-melanin (DHN-melanin) of A. fumigatus conidia inhibits 
phagolysosome acidification and allows conidia germination and escape from macrophages10, 11. In contrast, 
A. terreus conidia produce a different type of melanin, the so-called Asp-melanin, which protects conidia 
from UV radiation and reduces phagocytosis by amoeba12, but does not inhibit acidification of macrophage 
phagolysosomes10. Consequently, A. terreus conidia reside in the acidic environment of phagolysosomes, in which 
they show long-term persistence without inactivation. This long-term persistence was further confirmed by in 
vivo studies using a murine inhalation infection model13. Mice treated with high doses of corticosteroids were 
susceptible not only to A. fumigatus, but also to A. terreus infections. Bioluminescence imaging revealed that all 
mice infected with A. terreus conidia developed initial invasive disease, but only about 50% of mice succumbed 
to infection. Survivors showed no clinical signs of invasive disease at day 14 post infection. However, lung sec-
tions indicated the presence of conidia and plating of lung homogenates revealed that these conidia were still 
viable13. Furthermore, when immunocompetent mice were infected with A. terreus conidia, only a transient 
pro-inflammatory response was detected, which implied that infection was rapidly cleared. However, histopathol-
ogy at days 1, 3 and 5 after infection revealed significant amounts of intracellular conidia and determination of 
colony forming units showed that these conidia were still viable10. This indicates that persistence within immune 
cells is not only observed under immunocompromised conditions, but also in the immunocompetent situation. 
However, the subtypes of immune cells in which A. terreus conidia are able to persist have not been investigated yet.
Besides macrophages, dendritic cells (DCs) are another type of professional phagocytic cells that migrate 
to regional and draining lymph nodes where they present fungal antigens to T-cells and prime T-cell immune 
responses14, 15. Furthermore, some fungal pathogens, such as Histoplasma capsulatum are more efficiently 
restricted in the conidia to yeast transformation by DCs compared to macrophages, indicating an additional 
role of DCs in the control of fungal infections16. A. fumigatus conidia are efficiently phagocytosed by DCs via 
mannan receptors and C-type lectins of galactomannan specificity17. While a short-term interaction with DCs 
does not inactivate A. fumigatus conidia, three days after infection pulmonary DCs had transported conidia to 
draining lymph nodes and spleen without signs for viable fungal cells. This indicates the general ability of DCs 
to inactivate and degrade Aspergillus conidia for efficient antigen presentation17. Furthermore, it has been shown 
that DC recruitment in neutropenic mice increases during A. fumigatus infection and a depletion of DCs under 
this setting further impairs fungal clearance18. However, effective maturation of dendritic cells requires the inter-
action with neutrophils that stimulate DC maturation and migration to draining lymph nodes19. It has also been 
shown that both A. fumigatus and A. terreus infections trigger Th17/Th1 immune responses20. However, while 
A fumigatus also elicited Th2 activating cytokine production after infection, a Th2 immune response with A. 
terreus conidia has not been observed20. Th2 cytokines are promoted by IL-4 and IL-10 that are secreted by DCs 
mainly in response to hyphal growth, but expression of these cytokines is not promoted in A. terreus infections10. 
This finding suggests that A. terreus conidia may persist in DCs without germination and escape as observed in 
previous studies on macrophages10.
Taking into account that A. terreus infections are often refractory to antifungal treatment 4, show long term 
persistence in infected murine lungs10, 13 and display high dissemination rates in human patient populations6, 
we compared the interaction of A. terreus and A. fumigatus conidia with a human dendritic cell line. Our results 
suggest that A. terreus might hitchhike DCs for dissemination and gets protected from antifungal treatment.
Results
Selection of dendritic cells for interaction studies. To study the interaction of A. fumigatus and A. 
terreus conidia with dendritic cells we tested the suitability of the CD34+ human acute myeloid leukaemia cell 
line MUTZ-321 as an alternative to monocyte-derived human dendritic cells (moDCs) as MUTZ-3 cells have been 
shown to display the full range of functional antigen processing and presentation21. Similar to the differentiation 
of CD1a-positive and CD14-negative moDCs from peripheral blood monocytes after stimulation with human 
recombinant GM-CSF and IL-4 (Fig. S1A), MUTZ-3 cells were reproducibly differentiated into immature DCs 
(iDCs) when incubated in the presence of human recombinant GM-CSF and IL-422 (Fig. S1B). Therefore, subse-
quent studies were performed with MUTZ-3 cells differentiated into iDCs and relevant data were confirmed by 
the use or primary moDCs.
Phagocytosis of resting A. fumigatus and A. terreus conidia by iDCs. Previous in vitro studies 
showed that A. terreus conidia were rapidly phagocytosed by macrophages and remained resting in acidified 
phagolysosomes, whereas A. fumigatus conidia suppressed acidification and escaped by the formation of germ 
tubes10. When confronted with MUTZ-3 iDCs, 70% of A. fumigatus conidia were phagocytosed within 3 h and 
this rate declined with prolonged incubation time (55% at 6 h; Fig. 1A). This appeared mainly due to rapid germ 
tube formation and escape from DCs (Fig. 1B) and was in line with phagocytosis rates observed with murine 
fetal skin-derived DCs that showed about 70% internalization of A. fumigatus conidia after two hours with a 
decreasing rate after 4 h of confrontation17. On the contrary, despite higher galactomannan and β-glucan surface 
presentation of A. terreus conidia compared to A. fumigatus10, phagocytosis rate of A. terreus conidia was slightly 
delayed with 48% internalisation at 3 h. However, phagocytosis rate increased to about 75% at 6 h without signif-
icant germ tube formation of intracellular conidia (Fig. 1A). Microscopic analyses revealed some germination 
of A. terreus conidia after 9 h, but this germination was mainly restricted to conidia that had not been inter-
nalised by DCs (Fig. 1B). Intracellular conidia at this 9 h time point were either resting or showed some initial 
swelling. This implied that A. terreus conidia, once phagocytosed by iDCs do not tend to rapidly escape. These 
obvious differences in phagocytosis and fungal escape tempted us to determine growth rates of A. fumigatus and 
A. terreus conidia in the presence and absence of dendritic cells. During co-incubation with iDCs A. fumigatus 
showed a delay in the increase of optical density by only about 2 h compared to conidia grown in the absence of 
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iDCs (Fig. 1C), which is in agreement with the rapid germ tube formation observed by microscopic analyses. In 
contrast, while A. terreus conidia generally tend to germinate slower than those from A. fumigatus, germination 
in the presence of DCs was further delayed by at least 5 h (Fig. 1D) and most likely derived from conidia not 
phagocytosed by DCs. This delay was strictly dependent on the presence of viable DCs, as A. terreus germination 
speed was not delayed when conidia were incubated in the presence of fixed DCs (Fig. 1D).
Survival of A. terreus and A. fumigatus in confrontation with DCs. Due to the low rate of intracel-
lular germination of A. terreus conidia inside DCs, viability was determined by analysing the number of colony 
forming units (CFU) after lysis of DCs. Although A. fumigatus escaped DCs and displayed 100% viability after 
one hour of confrontation with MUTZ-3 iDCs, a significant reduction in viable counts were observed at three 
and six hours (Fig. 1E). However, due to the formation of dense mycelium from extracellular hyphae, no CFU 
determination at later time points was possible. In contrast to A. fumigatus, conidia of A. terreus were more 
resistant against DC-mediated killing. Survival rate of A. terreus conidia remained at about 100% after 3 h and 
only slightly dropped down to about 70–80% at 9 h (Fig. 1E). When experiments were repeated with human 
monocyte-derived moDCs comparable results as for MUTZ-3 iDCs were obtained for both fungi (Fig. 1F). This 
confirms the suitability of the MUTZ-3 cell line in analysing interactions of Aspergillus conidia with DCs and 
furthermore reveals that A. terreus conidia remain persistent and viable within DCs.
Figure 1. Phagocytosis, survival and escape of A. terreus and A. fumigatus in the interaction with DCs. (A) 
Phagocytosis of Aspergillus conidia by MUTZ-3 derived iDCs. Phagocytosis rate was determined after 1 h, 3 
h and 6 h of confrontation from about 1000 conidia that co-localised with DCs. (B) Microscopic visualisation 
of phagocytosis of A. fumigatus conidia at 6 h and A. terreus conidia at 9 h. FITC-labelled conidia were applied 
to DCs. Red Cy3-staining indicates fungal elements with contact to medium. Only extracellular A. terreus 
conidia form germ tubes as indicated by co-localisation of FITC and Cy3. Scale bar = 20 µm; BF, bright field. 
(C) Growth analysis of A. fumigatus conidia incubated in the presence and absence of DCs. (D) Growth analysis 
of A. terreus conidia incubated in the absence or presence of viable or fixed DCs. (E) Survival of A. fumigatus 
(1, 3, 6 h) and A. terreus (1, 3, 6, 9 h) conidia in co-incubation with MUTZ-3 derived iDCs. (F) Survival of A. 
fumigatus and A. terreus conidia (both at 3 h and 6 h) in co-incubation with moDCs. All data represent mean 
values obtained from three independent experiments. Data in (A) show mean values + SD. Statistical analysis 
was carried out by two-tailed Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.005).
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Analysis of persistence versus escape strategies. Macrophages acidify phagolysosomes by an active 
proton pumping mechanism to effectively degrade foreign antigens. A. fumigatus inhibits this acidification by 
DHN-melanin that coats conidia11 and contributes to survival within and rapid escape from macrophages. On the 
contrary, A. terreus conidia produce Asp-melanin12, which does not inhibit phagolysosme acidification and, conse-
quently, conidia reside within acidified phagolysosomes10. However, it has been shown that the escape of A. terreus 
conidia from macrophages can be stimulated by either inhibiting the V-H+-ATPase with Bafilomycin or by recom-
binant expression of the Aspergillus nidulans naphthopyrone synthase gene wA, which is responsible for production 
of a precursor molecule of DHN-melanin10. However, when we confronted A. terreus conidia expressing the wA 
gene with iDCs, germination showed the same delay (Fig. S2) as wild-type A. terreus conidia (Fig. 1D). This indi-
cates that the different type of melanin formed by A. terreus conidia is not the direct cause for persistence in DCs. 
Furthermore, lysotracker staining of DCs after phagocytosis of either A. fumigatus or A. terreus conidia did not 
indicate acidified phagolysosomes with either species (Fig. S3). This is in agreement with an active NOX2 dependent 
alkalinisation mechanism in the phagolysome membrane of DCs and is important for antigen cross-presentation 
and leads to a phagolysosome pH of about 823. This confirmed that an acidic environment is not the cause of delayed 
germination of A. terreus conidia. However, when we investigated the effect of environmental pH on germination of 
conidia, only a minor delay of germination was observed with A. fumigatus conidia at pH 8 compared to pH 6 and 7 
(Fig. 2A), whereas a delay of about three hours at a shift from pH 6 to 7 and a 6 h delay at a shift to pH 8 was observed 
with A. terreus conidia (Fig. 2B). Therefore, an alkaline environment might be one reason for trapping A. terreus 
conidia in DCs. However, an additional effect on inhibition of germination might derive from nutrient restriction 
within phagolysosomes. To test this assumption, we studied the germination of A. fumigatus and A. terreus conidia 
in serial dilutions of RPMI/glucose medium. Indeed, A. fumigatus conidia efficiently germinated without delay when 
RPMI/glucose medium was diluted by at least 64-fold (Fig. 2C), whereas germination speed of A. terreus conidia 
was strictly dependent on the concentration of nutrients (Fig. 2D). A subsequent investigation on A. terreus conidia 
germination in dependence on the limitation of specific nutrient sources indicated that either glucose or nitrogen 
limitation caused a delay in germination and limitation of both showed a cumulative effect (Fig. S4). As A. terreus 
and A. fumigatus both grow on minimal media, the overall nutritional requirements for both fungi appear to be 
similar. However, due to the unrestricted fast germination of A. fumigatus even at very low nutrient concentrations, 
the required nutrient threshold triggering germination seems much lower for A. fumigatus than for A. terreus. In 
conclusion, alkalinisation of phagolysosomes accompanied by a restricted nutrient supply traps A. terreus conidia in 
a resting state, whereas A. fumigatus efficiently germinates at pH 8 and shows rapid germination as soon as nutrients 
exceed a certain threshold value.
Efficacy of antifungals on persisting intracellular conidia. Alkaline pH and nutrient limitation 
appear as major reasons for trapping A. terreus but not A. fumigatus conidia in a resting intracellular state. From 
this result two questions arose: (i) are conidia persisting in DCs protected from environmental stressors such as 
Figure 2. Germination of Aspergillus conidia in dependence of environmental pH and nutrient availability. (A,B) 
Effect of medium pH on germination of A. fumigatus (A) and A. terreus (B). (C,D) Germination of A. fumigatus 
(C) and A. terreus (D) conidia in dependence on nutrient availability. RPMI/glucose medium was serially diluted 
and growth was monitored as increase in optical density at 600 nm (OD600) using a microplate reader. Growth 
curves in (A–D) result from two independent experiments each containing three technical replicates.
www.nature.com/scientificreports/
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antifungals and (ii) how long can conidia survive within DCs? To address these questions we selected the anti-
mycotics amphotericin B (AMB) and voriconazole (VOR) that were used in a concentration of 10 µg/ml, which 
is far above the MIC values of both drugs for the selected strains with about 0.5 µg/ml (AMB) and 0.25 µg/ml 
(VOR) for A fumigatus and 1 µg/ml (AMB) and 0.25 µg/ml (VOR) for A. terreus as determined by broth dilution 
tests. Therefore, we expected that all extracellular fungi that had not been phagocytosed or escaped from DCs 
were inactivated by the antifungals. Indeed, when conidia were incubated without iDCs in the presence of these 
antimycotics and analysed for CFUs after 24 h, about 100% of A. fumigatus conidia and about 99.5% of A. terreus 
conidia were inactivated with either drug (Fig. 3A), showing that the selected concentrations of both antimycotics 
were highly effective. Subsequently, A. fumigatus and A. terreus conidia were first pre-incubated for six hours in 
the presence of iDCs to allow for phagocytosis of extracellular conidia before antimycotics were added and CFUs 
were analysed after 24 h (Fig. 3A). Only about 1% of A. fumigatus conidia remained viable after this procedure, 
indicating that conidia that escaped DCs were inactivated by extracellular drugs and conidia that failed to escape 
were inactivated by DCs. In contrast, in the presence of DCs about 60% of A. terreus conidia survived AMB and 
40% the VOR treatment. This implies that intracellular conidia were well protected from antifungal treatment 
and not efficiently inactivated by DCs. To test for a long-term persistence of A. terreus within DCs the experiment 
was repeated, but analysis of CFUs was performed after three days of incubation (Fig. 3B). While about 99.9% 
of free extracellular conidia were inactivated by either drug, 30% viable conidia were still re-isolated from DCs 
under either treatment. This experiment confirmed both assumptions from above: A. terreus conidia show an 
intracellular long-term persistence within DCs, which is accompanied by a protection from antifungal treatment.
DC activation in the presence of A. fumigatus and A. terreus conidia. Activation of DCs is required 
to trigger an adaptive immune response against Aspergillus infections24. In this respect, activation of the transmi-
gration marker CCR7 is of special importance as it allows migration of DCs to lymph nodes for T-cell interaction 
and activation during Aspergillus infection24. Since A. terreus conidia showed a persistent phenotype within DCs, 
we wondered whether these conidia trigger activation and maturation of iDCs. Therefore, we first determined 
expression of the activation markers CCR7, CD83, CD80 and MHCII after short term incubation (6 h) with viable 
or UV-inactivated A. fumigatus and A. terreus conidia. Only the confrontation with viable A. fumigatus conidia 
resulted in a significant induction of CCR7 expression accompanied by induction of the activation marker CD83 
and a similar trend was observed by either using MUTZ-3 DCs or moDCs (Fig. S5). UV-inactivated A. fumig-
atus conidia as well as viable or UV-inactivated A. terreus conidia did not induce CCR7 expression, but slightly 
induced expression of CD83 (Fig. S5C). Since maturation of DCs may take longer than 6 h especially when no 
other co-stimulatory cytokines or interactions with immune cells such as neutrophils are present19, we aimed 
in the characterisation of DC activation at later time points. To avoid complete destruction of DCs by extra-
cellular hyphae, we added AMB after 6 h of confrontation, but lowered AMB concentration to 2 µg/ml to avoid 
perturbance of dendritic cell function. Such treatment has previously been shown not to grossly affect response 
of human DCs in the interaction with A. fumigatus conidia24. Activation marker expression was studied after a 
further incubation of 18 h and was normalised to cells treated with AMB but not confronted with conidia. As 
expected24, CCR7 and to a minor extend CD62L (not shown) as well as CD83, CD80, CD54 and MHCII were 
strongly expressed on DCs confronted with viable A. fumigatus conidia (Fig. 4). This indicates that these DCs 
matured and became activated for transmigration to lymph nodes through expression of CCR7 for stimulation of 
naïve T-cells. In contrast, while CD83, CD80, CD54 and MHCII, though to a lower extent, were also upregulated 
by UV-inactivated A. fumigatus and both, viable and UV-inactivated A. terreus conidia, no significant induction 
of CCR7 surface expression was observed for those pathogen preparations (Fig. 4). These partially activated DCs 
are assumed not to produce T-cell activating cytokines or stimulate immunogenic T-cells25.
Figure 3. Effect of antifungals on survival of Aspergillus conidia in the presence of iDCs. (A) Effect of 
amphotericin B (AMB, 10 µg/ml) or voriconazole (VOR, 10 µg/ml) on survival of A. fumigatus and A. terreus 
conidia in the presence or absence of MUTZ-3-derived iDCs. Conidia were pre-incubated with DCs for 6 h 
before addition of antifungals to avoid inactivation of conidia prior to phagocytosis. DCs were lysed after 24 
h for determination of CFUs. (B) Analysis of long-term persistence of A. terreus conidia in MUTZ-3-derived 
iDCs in the presence of antifungals. DCs were lysed after 72 h of incubation and CFUs were determined. All 
data show mean values + SD from three independent experiments. Statistical significance was calculated by 
using the two-tailed Student’s t-test (***p < 0.005).
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Cytokine production of DCs in response to A. fumigatus and A. terreus conidia. From analyses of 
activation markers we assumed that only DCs confronted with viable A. fumigatus conidia are stimulated to pro-
duce cytokines that are critical to elicit innate and adaptive immune responses. Therefore, we analysed Th1, Th2, 
immunosuppressive and pro-inflammatory cytokine production of DCs in response to viable and UV-inactivated 
A. fumigatus and A. terreus conidia after 24 h of confrontation (Fig. 5). When incubated with viable A. fumigatus 
conidia DCs produced pro-inflammatory cytokines, such as IL-1β and TNF-α as well as T-cell stimulating IL-12 
(Th1) and IL-4 (Th2) cytokines. In contrast, neither confrontation with UV-inactivated A. fumigatus nor viable or 
UV-inactivated A. terreus conidia resulted in a significant cytokine response of DCs (Fig. 5A-D), whereby the lack 
of cytokine production was not mediated by production of the immunosuppressive cytokines TGF-β and IL-10 
(Fig. 5E-F). Therefore, we conclude that persisting A. terreus conidia do not induce a strong pro-inflammatory or 
immune regulatory response in DCs.
Effect of TNF-α stimulation on DCs confronted with A. terreus conidia. Our analyses revealed that 
A. terreus conidia persist within DCs, but neither trigger a significant cytokine response (Fig. 5) nor stimulate the 
expression of the transmigration markers CCR7 and CD62L (Fig. 4). However, due to their ability to transmigrate 
for antigen presentation, DCs appear to depict ideal candidates for transporting A. terreus to different body sites. 
This is of special interest as clinical reports have indicated that aspergillosis caused by A. terreus is frequently asso-
ciated with high dissemination rates to secondary organs6. Previous studies showed that corticosteroid treated 
mice infected with high doses of A. terreus conidia display elevated levels of TNF-α in lung tissues, which might 
results from the germination of extracellular conidia13. Therefore, we stimulated DCs containing persisting A. 
terreus conidia with 100 ng/ml TNF-α and inhibited extracellular growth of A. terreus conidia by amphotericin B 
(Fig. 6). Indeed, TNF-α not only significantly stimulated the expression of the activation markers CD83, CD80, 
CD54 and MHCII, but also of the transmigration marker CCR7, indicating that TNF-α led to a full maturation 
Figure 4. Expression of DC activation markers after confrontation with A. fumigatus and A. terreus conidia. 
DCs were pre-incubated for 6 h with UV-inactivated or viable A. fumigatus or A. terreus conidia before 
amphotericin B (2 μg/ml) was added to inhibit extracellular fungal growth. Expression levels were normalised 
to expression levels of uninfected DCs (dashed line). Marker expression was determined after a total incubation 
time of 24 h. (A) CCR7, (B) CD54, (C) CD83, (D) CD80 and (E) MHC II (HLA-DR). Data represent mean 
values + SD from three independent experiments. Statistics were performed by one-way ANOVA (*p < 0.05, 
**p < 0.01, ***p < 0.005).
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of iDCs (Fig. 6A-E). However, when the intracellular survival of A. terreus conidia was investigated after 24 h, 
about 60% of conidia remained viable and this viability was undistinguishable from iDCs that were not stimulated 
by TNF-α (Fig. 6F). Therefore, TNF-α stimulation induces migration of DCs harbouring persisting A. terreus 
conidia and, therefore, might support fungal dissemination.
Discussion
Invasive fungal infections remain a great challenge in critically ill patients and especially patients suffering from 
haematological malignancies are highly susceptible for invasive aspergillosis2. As A. fumigatus is most frequently 
re-isolated from patients with invasive aspergillosis, studies on immune interactions have strongly focused on 
this species. However, we have previously shown that macrophage interaction of A. terreus is significantly dif-
ferent from that observed with A. fumigatus10. While A. fumigatus inhibits phagolysosome acidification by its 
DHN-melanin layer and rapidly germinates and pierces the phagocytic cell, A. terreus has been shown to reside 
in acidified phagolysosomes10. Persistence within macrophages is at least partially due to the different type of 
melanin produced by A. terreus12, as expression of the naphtopyrone synthase wA increased A. terreus germina-
tion rates. However, as DCs do not tend to acidify their phagolysosomes23, it is well conceivable that the type of 
melanin does not influence persistence and escape in this type of immune cells and, in agreement, the expression 
of wA in A. terreus conidia did not trigger the escape from DCs.
Our analyses on the reasons why A. terreus conidia remain dormant within DCs indicated that both, the 
alkaline pH in DC phagolysosomes as well as restriction from nutrient supply significantly delays germination of 
A. terreus conidia. Strikingly, germination rates of A. fumigatus conidia were quite similar in a range from pH 6 
to 8 and even at a very limited nutrient supply germination was initiated without any significant delay. Therefore, 
while the nutritional supply in DCs seems to exceed the required threshold value for germination of A. fumig-
atus conidia, the phagolysosomal environment forms a natural barrier for A. terreus germination and indicates 
that DCs do not need to produce specific growth inhibitory factors to control A. terreus germination. However, 
since A. terreus conidia can be stored for several weeks in nutrient limited solutions such as phosphate-buffered 
saline or water without significant loss in viability, they easily survive the nutrient limited environment within 
phagolysosomes. In addition, as conidia do not tend to germinate under these conditions, they may be treated as 
inactive antigen particles that induce expression of activation markers on dendritic cells without stimulating mat-
uration by expression of the transmigration marker CCR724. Unfortunately, these activated but not matured DCs 
may act as negative regulators of T-cell immune response. Interaction of T-cells with these so-called steady-state 
DCs inhibits their ability to develop into immunogenic effector T-cells, but stimulates development of regulatory 
T-cells that dampen the immune response26.
Figure 5. Cytokine production by DCs confronted with A. fumigatus and A. terreus conidia. MUTZ-3-derived 
iDCs were pre-incubated for 6 h with UV-inactivated or viable A. fumigatus or A. terreus conidia before 
amphotericin B (2 μg/ml) was added to inhibit extracellular fungal growth. Brefeldin A was added after a total 
of 24 h and cytokine production was determined 6 h later. Cytokine expression was normalised to expression 
levels of uninfected DCs (dashed line). (A) TNF-α, (B) IL-1β, (C) IL-12/IL-23 p40, (D) IL-4, (E) TGF-β and (F) 
IL-10 production. Bar diagrams indicate mean values + SD from three independent experiments. Statistics were 
performed by using one-way ANONA (*p < 0.05, **p < 0.01, ***p < 0.005).
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In agreement with the formation of steady-state DCs after phagocytosis of A. terreus conidia neither signifi-
cant induction of the pro-inflammatory cytokine TNF-α, nor other cytokines was observed. This is in line with 
observations on A. fumigatus, in which β-glucan exposure from germinating conidia was required to trigger 
TNF-α production in bone marrow and alveolar macrophages as well as dendritic cells. In contrast, heat-killed A. 
fumigatus conidia were not immune stimulatory27 and in our experiments UV-inactivated A. fumigatus conidia 
behaved comparable in DC interactions as viable or UV-inactivated A. terreus conidia.
While persisting A. terreus conidia may cause a down-regulation of the immune response, they may also explain the 
difficulties to treat A. terreus infections with antifungals despite the fact that, except for AMB, antifungal susceptibility 
of A. terreus is largely comparable to that of A. fumigatus4. It has been observed that significantly higher drug concen-
trations are required in therapy of A. terreus infections than assumed from in vitro susceptibility analyses and it virtually 
affects treatment with all common antimycotics4. This may, at least partially, be due to a fungistatic effect of drugs on A. 
terreus, which results in large differences between minimal inhibitory and minimum fungicidal drug concentration28. 
However, at 10 µg/ml of AMB or VOR both drugs showed high fungicidal activity on A. terreus, which was completely 
different in the presence of DCs. Within DCs between 40 and 60% of A. terreus conidia survived this drug treatment for 
the first 24 h and about 30% viable conidia were still re-isolated after three days. Therefore, persistence within DCs may 
not only tune down immune activation, but also supports evasion of A. terreus from antifungal treatment.
For using DCs as a vehicle for dissemination as frequently observed with A. terreus infections6, full matu-
ration and expression of transmigration markers is required. As observed in moribund corticosteroid treated 
mice, A. terreus can indeed elicit a strong TNF-α response in infected lungs once hyphal elements are formed13. 
Figure 6. Effect of extracellular TNF-α on DCs containing persisting A. terreus conidia. MUTZ-3-derived 
iDCs were pre-incubated for 6 h with A. terreus conidia before amphotericin B (2 μg/ml) was added. Medium 
was either supplement with 100 ng/ml TNF-α or left untreated (control). Cells were incubated for a further 
18 h before expression of (A) CCR7, (B) CD54, (C) CD83, (D) CD80 and (E) MHC II was analysed by flow 
cytometry. Data were normalised to expression levels from uninfected DCs without TNF-α supplementation 
(dashed line). (F) Survival of persisting A. terreus conidia under TNF-α treatment. Cells were lysed after 24 h 
and CFUs were determined. Statistics were performed by using the two-tailed Student’s t-test. All data represent 
mean values + SD from three independent experiments (***p < 0.005).
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Alternatively, TNF-α production may be caused by bacterial (co-)infection as common in critically ill patients29. 
We have shown that external addition of TNF-α results in complete maturation and expression of CCR7 on 
DCs containing persisting A. terreus conidia, without resulting in increased conidia inactivation rates. TNF-α 
and IFN-γ activate production of reactive oxygen species in macrophages, which has been described to support 
clearance of intracellular fungal pathogens8, 9. However, in case of A. terreus infections, this appears of minor 
importance. A transient increase in IFN -γ in immunocompetent mice infected with A. terreus conidia has been 
observed10, which is in line with the Th1 immune response described for A. terreus infections20. However, as via-
ble conidia remain persistent in infected lung tissues10, this clearance mechanism seems not effective for A. terreus 
conidia. Even more, the activation of DCs by these external cytokines may cause the initiation of transmigration 
to draining lymph nodes and spleen, transporting viable A. terreus conidia to organs outside the pulmonary tract. 
However, it needs to be mentioned that providing a definite role for the observed persistence of A. terreus conidia 
in dendritic cells during pathogenesis will require the in vivo detection of DCs carrying viable fungal elements.
In conclusion, MUTZ-3 cells are well suited for the investigation of Aspergillus conidia interactions with den-
dritic cells. Parallel studies on the survival of A. fumigatus and A. terreus conidia with MUTZ-3 DCs and moDCs 
showed identical results and our analyses on A. fumigatus conidia matched results previously obtained from primary 
or monocyte-derived DCs. As previously observed for macrophages, A. terreus follows a sit and wait strategy in DCs 
and may use these cells for dissemination once an external trigger stimulates DCs maturation. Most importantly, A. 
terreus was protected from antifungal treatment inside DCs, which could explain treatment failure despite in vitro 
susceptibility of A. terreus against antifungals4. Finally, we speculate that long-term persistence of A. terreus conidia 
within immune effector cells such as macrophages or dendritic cells may also occur in immunocompetent persons 
as previously observed in immunocompetent mice10. Thus, once an immunosuppressive regimen is applied these 
conidia may be released from immune cells and may cause invasive aspergillosis with high dissemination rates.
Material and Methods
Fungal strains, cultivation and preparation of conidia suspensions. A. fumigatus CBS 144.89 (CBS, 
Utrecht, Netherlands), A. terreus SBUG844 (HKI strain collection, Jena, Germany30) and A. terreus SBUG844 
expressing the A. nidulans wA gene10 were used in this study. For conidia preparation, fungi were cultivated 
at 37 °C on solid 50 mM glucose containing Aspergillus minimal media with nitrate as nitrogen source and 2% 
agar30. A. fumigatus conidia were harvested after 3–4 and A. terreus conidia after 5–6 days of incubation. Conidia 
were harvested by overlaying plates with 10 ml sterile phosphate-buffered saline (PBS) and filtered through 40 μm 
cell-strainers. Conidia suspensions were washed twice in PBS and counted by using a haemocytometer.
Labelling and UV-inactivation of conidia. For phagocytosis assays conidia were pre-labelled with fluo-
resceine isothiocyanate (FITC) as described previously10. In brief, 1–2 × 108 conidia were suspended in 10 ml of 
0.1 M sodium carbonate solution containing 0.1 mg/ml FITC and incubated at 37 °C for 1 hour. Conidia were 
washed twice in sterile PBS and diluted to selected concentrations for phagocytosis assay. For UV inactivation 1 ml 
of conidia suspension containing 2–3 × 108 conidia were poured in small petri dish (5 cm in diameter). UV treat-
ment was performed with the sterilisation programme of a GS Gene Linker UV chamber (BioRad Laboratories). 
Complete inactivation of conidia (>99.9%) was confirmed by spreading aliquots on malt extract agar plates.
Differentiation of DCs from human monocytes. Human monocyte-derived DCs were generated as previ-
ously described31. In brief, human peripheral blood mononuclear cells (PBMCs) were harvested by density gradient 
centrifugation using Biocoll (Biochrom AG). CD14+ primary human monocytes were further purified from PBMCs 
by CD14+ microbeads (Miltenyi Biotech) using a magnetic cell sorting system. Primary monocytes were differenti-
ated into monocyte-derived dendritic cells (moDCs) by treatment with 800 U/ml human recombinant GM-CSF and 
1,000 U/ml human recombinant IL-4 (Miltenyi Biotech). At day six cell surface marker expression (Fig. S1A) and 
phenotype of immature moDCs was monitored prior to performing conidia interaction studies.
Cultivation and differentiation of MUTZ-3 cells. The MUTZ-3 cell line derived from a human acute mye-
lomonocytic leukaemia (DSMZ, Braunschweig, Germany) was kept in minimal essential alpha medium (MEM α, 
Gibco) supplemented with 20% of heat-inactivated fetal bovine serum (FBS) and 50 U/ml of recombinant human 
GM-CSF (Miltenyi Biotec). To differentiate MUTZ-3 cells into iDCs, 1–2 × 105 cells/ml were incubated for 7 days 
in the presence of 300 U/ml human recombinant GM-CSF and IL-4 (Miltenyi Biotec)22. LSRII flow cytometry was 
applied to analyse expression of surface markers (Fig. S1B), using FITC-anti-human CD14, PE-anti-human CD1a, PE/
Cy7-anti-human DC-SIGN and APC-anti-human CD83 (all BioLegend, London, UK). Differentiated iDCs were kept 
in MEM α medium supplemented with 20% of heat-inactivated FBS during Aspergillus conidia interaction studies.
Phagocytosis assays. iDCs (3 × 105 cells) were transferred to wells of a 24-well plate containing 
polylysine-coated coverslips (12 mm diameter) and FITC-labelled conidia of A. fumigatus or A. terreus were 
added at a multiplicity of infection (MOI) of 0.5. At selected time points plates were centrifuged at 200 × g to 
pellet cells and fixed over night at 4 °C in the presence of 4% of paraformaldehyde. After washing with PBS, 
cells were blocked for 15 min at room temperature (RT) with Fc receptor blocking solution (Human TruStain 
FcXTM, BioLegend). Plates were centrifuged again for 10 min at 200 × g before blocking solution was removed. 
To stain conidia not phagocytosed by DCs, a rabbit anti-conidia antiserum (kindly provided by Frank Ebel, 
Munich) diluted 1:100 in 1% bovine serum albumin (BSA, sigma) was added and incubated for 1 hour at RT. 
After washing with PBS, Cy3-labelled anti-rabbit IgG antibody diluted 1:300 in 1% BSA was added and incubated 
for 1 hour at RT in the dark. Coverslips were washed three times with PBS, mounted in ProLong Gold mounting 
solution (Invitrogen) and analysed by fluorescence microscopy. Conidia co-localising with DCs were counted. 
Phagocytosis rates were calculated from FITC+, Cy3− conidia divided by the total number of conidia counted 
resulting in the percentage of phagocytosis. At least 900 conidia were analysed in each experimental group.
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Analysis of conidia germination. A. terreus and A fumigatus conidia (105/well) were cultivated at 37 °C in a 
CO2 incubator in 96-well plates in the absence or presence of DCs (MOI = 1). Optical density of cultures (OD600) was 
analysed at 600 nm every hour. To investigate the effect of pH or nutrient limitation on germination of Aspergillus 
conidia, RPMI 1640 (Sigma) with 2% glucose was adjusted to pH 6–8 or MOPS-buffered medium (pH 6.5) was seri-
ally diluted with PBS. Cells were incubated at 37 °C in a Multiskan Go microplate spectrophotometer (Thermo) and 
OD600 was taken every 15 min. Similarly, Aspergillus minimal medium with ammonium chloride as nitrogen source 
was serially diluted and analysed for conidia germination. To analyse the effect of carbon or nitrogen starvation, 
either glucose or ammonium chloride were serially diluted, but all other components were kept constant.
Killing and antifungal sensitivity of conidia in the presence of DCs. DCs (1 × 106 cells/well) were 
co-incubated with Aspergillus conidia at an MOI of 0.1 in 6 well plates. DCs, including all extracellular fungal 
material, were scraped at 1 h, 3 h, 6 h and 9 h and lysed by the addition of sterile cold ddH2O with subsequent 
centrifugation at 2000 × g to release and collect intracellular conidia. Serial dilutions of cell lysates were plated on 
malt extra agar plates and incubated for 24–40 h at 37 °C for determination of CFUs. Survival rates were calcu-
lated with reference to CFUs from conidia not confronted with DCs. For antifungal sensitivity assays DCs were 
allowed to phagocytose Aspergillus conidia for 6 h prior to addition of 10 μg/ml AMB or VOR. DCs were collected 
and lysed as described after a total of either 24 h or 72 h. Serial dilutions of lysates were plated on malt extract agar 
plates and CFUs and survival rates were determined after 40 h of incubation at 37 °C as described above.
Lysotracker staining. DCs and MH-S cells (3 × 105 cells/well) were co-incubated with FITC-labelled 
Aspergillus conidia at an MOI of 0.5 on polylysine coated coverslips (12 mm) in 24 well plates. After 3 h plates 
were centrifuged at 200 × g for 10 min and medium was removed. Pre-warmed fresh medium containing 200 nM 
lysotracker (DND-99, Invitrogen) was added and incubation was continued for 1 h to allow for staining of phagolys-
osomes. After a brief centrifugation step, cells were fixed for 15 minutes with 4% paraformaldehyde. After washing 
with PBS, coverslips were mounted with ProLong Gold mounting solution and analysed by fluorescence microscopy.
Analysis of DC activation markers and cytokine production. DCs (106/well) were co-incubated with 
viable or UV-inactivated Aspergillus conidia (MOI = 2) in 6 well plates. For short-term activation studies cells 
were analysed after 6 h of co-incubation, whereas in long-term interaction studies amphotericin B (2 μg/ml) 
was added after 6 h to inhibit extracellular fungal growth. Cells were collected at 24 h and blocked for 10 min 
at RT with Fc receptor blocking solution (Human TruStain FcXTM). DCs (2–3 × 105 cells) were treated with 1 
μg/ml FITC-anti-human CCR7, APC-anti-human CD54, PE-anti-human CD80 or PerCP-anti-human HLA-DR 
(MHCII) monoclonal antibodies (BioLegend) diluted by FACS staining buffer (dPBS supplemented with 1% 
heat-inactivated FBS) and incubated for 30 min in the dark at 4 °C. After two washes in FACS staining buffer, 
cells were fixed in 1% paraformaldehyde and subjected to flow cytometry (LSRII). For preparation of intracel-
lular cytokine staining, Brefeldin A (5 μg/ml, Fluka) was added 6 h before harvest to block intracellular protein 
transport. Cells were collected at 30 h and treated with Fc receptor blocking solution for 10 min at RT. Cells 
were fixed with 4% paraformaldehyde for 20 min at 4 °C. To make cell membranes permeable, fixed cells were 
washed with perm wash buffer (FACS staining buffer containing 0.1% saponin). The cells were stained at 4 °C 
for 30 min with 1 μg/ml of either PE-anti-human TNF-α, FITC-anti-human IL-1β, PE-anti-human IL-12/IL-23 
p40, PE-anti-human IL-4, PE-anti-human TGF-β or APC-anti-human IL-10 monoclonal antibodies (BioLegend) 
prepared in perm wash buffer. After washing with perm wash buffer, the cells were left in 1% paraformaldehyde 
at 4 °C in the dark before analysed by flow cytometry. Mean fluorescence intensity (MFI) was analysed by FlowJo 
software and normalised to mock-infected DCs.
Statistical analyses. Comparisons between multiple groups were analysed by one-way analysis of variance 
(ANOVA) followed by Tukey’s multiple comparison test using GraphPad Prism (GraphPad Software). Statistical 
differences between two groups were analysed by two-tailed Student’s t-test.
Ethics statement. Human peripheral blood for generation of moDCs was collected from healthy volunteers 
after written informed consent. The study was conducted in accordance with the Declaration of Helsinki, all 
protocols were approved by the Ethics Committee of the University Hospital Jena (permit number: 273-12/09).
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